Business Context and Reporting Period
This Form 8-K filing by Minerva Neurosciences, Inc. (NERV) is dated May 31, 2023, and signed on June 2, 2023. The report addresses a critical corporate governance event regarding the company's listing status on The Nasdaq Capital Market.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The only financial metric referenced is the Market Value of Listed Securities, which has been below the required minimum of $35 million for the last 30 consecutive business days prior to the initial notice.
Material Changes
- Delisting Notice: On May 31, 2023, the company received a second written notice from Nasdaq stating that its securities will be delisted from The Nasdaq Capital Market due to continued non-compliance with Listing Rule 5550(b)(2).
- Compliance Deadline: The company failed to regain compliance by the May 30, 2023 deadline.
- Historical Context: The initial notice of non-compliance was received on December 1, 2022, as previously disclosed in an 8-K filed on December 2, 2022.
Outlook, Management Commentary, and Risks
- Management Action: The company intends to timely request a hearing before a Nasdaq Hearings Panel. This request will stay any suspension or delisting action pending the hearing's completion.
- Potential Extension: The Hearings Panel has discretion to grant a further extension not to exceed November 27, 2023.
- Risks and Contingencies: There is no assurance that the Panel will grant an extension or that the company will ultimately regain compliance with all applicable requirements for continued listing.
Investor Verification Checklist
- Verify the current status of the hearing request with the Nasdaq Hearings Panel.
- Monitor the company's Market Value of Listed Securities to assess if it has risen above the $35 million threshold.
- Check for any subsequent filings regarding the outcome of the hearing or the granting of an extension.
- Review the company's capitalization and recent stock price trends to understand the root cause of the market value decline.